U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173244) titled 'A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors' on Aug. 26.
Brief Summary: This prospective, multicenter, non-interventional, observational, real-world study was designed to evaluate the safety and efficacy of an adebrelimab-based regimen in patients with advanced solid tumors.
Study Start Date: Sept. 15
Study Type: OBSERVATIONAL
Condition:
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Gastrointestinal Cancers
Intervention:
DRUG: Adebrelimab
adebrelimab-based regimen
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tianjin First Central Hospital
Information provid...